Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-16
2011-08-16
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S139000
Reexamination Certificate
active
07998977
ABSTRACT:
4-[5-(2-Amino-ethanesulfonyl)-isoquinolin-7-yl]-phenol or a pharmaceutically acceptable salt thereof or a hydrate of the compound or the salt thereof as Akt inhibitors that are antineoplastic and/or antiviral agents as well as compositions comprising these compounds and methods of using these compounds.
REFERENCES:
patent: WO01/91754 (2001-12-01), None
patent: WO2004/094386 (2004-11-01), None
patent: WO2005/011697 (2005-02-01), None
patent: WO2005/054202 (2005-06-01), None
patent: WO 2005054202 (2005-06-01), None
Reuveni, H., “Toward a PKB Inhibitor: Modification of a Selective PKA Inhibitor by Rational Design,” Biochemistry, 2002, 41, pp. 10304-10314.
Aburub Aktham
Dai Jenny Pingqi
Joseph Sajan
Li Renhua
Myers Michael Ray
Eli Lilly and Company
Hostettler Danica
Jean-Louis Samira
Padmanabhan Sreeni
Tucker Tina M.
LandOfFree
Inhibitors of AKT (protein kinase B) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of AKT (protein kinase B), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of AKT (protein kinase B) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643175